Project Grant HT94252310503
Award Date
7/1/23
Completion Date
6/30/27
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The Department of the Army Medical Command awarded a $3,874,682 Project Grant to The Ohio State University Office of Sponsored Programs under the Military Medical Research and Development program. The grant will fund research from July 1, 2022 to June 30, 2026 to investigate the mechanisms of metastasis suppression and develop translational applications in thyroid cancer. As part of the Military Medical Research and Development program's goal to transform military and public health through...
This $1,574,999.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Ohio State University to investigate SLIT2 as a novel approach for targeting metastatic breast cancer. The award period runs from June 15, 2025 to June 14, 2028. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions to critical health...
The U.S. Defense Health Agency awarded a $1,562,257 project grant under the Military Medical Research and Development program (CFDA 12.420) to The Ohio State University. The grant supports research to target de novo pyrimidine synthesis as a potential treatment for ovarian cancer. The project will involve collaboration between researchers at The Ohio State University and the University of South Florida, who will design experiments to investigate the role of pyrimidine synthesis in ovarian cancer...
This federal Project Grant award of $1,317,976.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at The Ohio State University to target the RAL G proteins for the treatment of triple-negative breast cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical investigations in cancer treatment. The award has a performance period from...
The federal Project Grant award of $624,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award, with a performance period from September 1, 2025, to August 31, 2027, will fund a comprehensive in vivo phenotyping study of fusion-driven pediatric rhabdomyosarcomas conducted by the...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $551,250.00 to The Ohio State University to support research on PPP2R1B IN DEDIFFERENTIATED LIPOSARCOMA. The project will be performed in Columbus, OH and run from Sep 30, 2023 through Sep 29, 2026. The Ohio State University has a history of conducting biomedical research and providing clinical trial coordination services to federal agencies like the National...
This $472,498 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at The Ohio State University to target the UPP1-mediated pyrimidine salvage pathway to prevent ovarian cancer recurrence. The research aims to develop innovative approaches to disease prevention, diagnosis, and treatment for conditions relevant to military personnel and the broader public. This 2-year project,...
The Defense Health Agency awarded a $472,251.00 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development program (CFDA 12.420) to identify novel compounds for the treatment of pPDAchordoma and other SMARCB1-deficient rare tumors. The award period is from August 1, 2023 to July 31, 2026. Through this grant, OHSU will conduct research and development activities to discover and evaluate new drug compounds that could potentially treat these...
The Ohio State University will receive $1,181,604 under a four-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The funding will support research into developing new methods to access extracellular vesicle MDM2 DNA cargo as a potential biomarker for liposarcoma. The grant aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for...
The Department of the Army Medical Command awarded a $472,500 Project Grant (CFDA 12.420 - Military Medical Research and Development) to The Ohio State University to explore the role of CHD1L expression as an early event in high-grade serous ovarian cancer. This 2-year research project, with a performance period from June 1, 2024 to May 31, 2026, aims to advance the understanding of this form of ovarian cancer to support the development of improved diagnostic tools and treatments for military...